- Home
- REAX vs LENZ Comparison
REAX vs LENZ Comparison
Compare REAX & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAX
- LENZ
- Stock Information
- Founded
- REAX 2018
- LENZ 2019
- Country
- REAX United States
- LENZ United States
- Employees
- REAX N/A
- LENZ N/A
- Industry
- REAX
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- REAX
- LENZ Health Care
- Exchange
- REAX Nasdaq
- LENZ Nasdaq
- Market Cap
- REAX 909.7M
- LENZ 729.6M
- IPO Year
- REAX N/A
- LENZ 2021
- Fundamental
- Price
- REAX $4.12
- LENZ $23.00
- Analyst Decision
- REAX Strong Buy
- LENZ Strong Buy
- Analyst Count
- REAX 2
- LENZ 6
- Target Price
- REAX $6.00
- LENZ $38.00
- AVG Volume (30 Days)
- REAX 816.2K
- LENZ 251.1K
- Earning Date
- REAX 03-06-2025
- LENZ 03-19-2025
- Dividend Yield
- REAX N/A
- LENZ N/A
- EPS Growth
- REAX N/A
- LENZ N/A
- EPS
- REAX N/A
- LENZ N/A
- Revenue
- REAX $1,264,639,000.00
- LENZ N/A
- Revenue This Year
- REAX $26.91
- LENZ N/A
- Revenue Next Year
- REAX $19.13
- LENZ $535.40
- P/E Ratio
- REAX N/A
- LENZ N/A
- Revenue Growth
- REAX 83.50
- LENZ N/A
- 52 Week Low
- REAX $3.02
- LENZ $14.42
- 52 Week High
- REAX $6.75
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- REAX 38.15
- LENZ 39.28
- Support Level
- REAX $3.97
- LENZ $24.10
- Resistance Level
- REAX $4.25
- LENZ $27.30
- Average True Range (ATR)
- REAX 0.20
- LENZ 1.90
- MACD
- REAX -0.01
- LENZ -0.15
- Stochastic Oscillator
- REAX 28.48
- LENZ 3.17
About REAX The Real Brokerage Inc.
The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.